Jiangsu Recbio Technology Co., Ltd. (RECBIO-B, 02179) announced that its board of directors will convene on Tuesday, 24 March 2026. The meeting’s agenda includes:
1. Reviewing and approving the consolidated annual results for the financial year ended 31 December 2025.
2. Considering the declaration of a final dividend, if any.
The announcement was issued on 12 March 2026 and signed by Chairman Mr. Xu Haoyu. As of the announcement date, the Board comprises one non-executive chairman, three executive directors, four additional non-executive directors, and four independent non-executive directors.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments